This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Preliminary Schedule

*Subject to Change

Friday, February 28, 2020

  • 07:15 08:00

    Registration/ Inscription

    (Breakfast/Petit Déjeuner)
  • 08:00 08:15

    Welcome and Introductions | Mot de Bienvenue

    Dr. Naglaa Shoukry (Chair of the Canadian Network for Hepatitis C) | Université de Montréal
    Dr. Curtis Cooper (Symposium Chair) | The Ottawa Hospital Research Institute
    Dr. Angela Crawley (Symposium Co-Chair) | The Ottawa Hospital Research Institute

  • 08:15 09:15

    Biomedical Research ‑ HCV Vaccine Development and Related Studies

    Dr. Seung-Hwan Lee (Co-Chair) | University of Ottawa 
    Dr. Joyce Wilson (Co-Chair) | University of Saskatchewan
    CanHepC trainees introducing Plenary Speakers  

    8:15 - 8:35 | Session - Dr. Ellie Barnes | Oxford University, UK
    8:35 - 8:55 | Session - Dr. John Law | University of Alberta, Canada
    8:55 - 9:15 | Questions/Panel Discussion 

  • 09:15 09:45

    Oral Presentations

    9:15 - 9:30 | Oral Abstract 1 | Differential gene expression of circulating CD8 T cells of cirrhotic HCV-infected individuals identifies pathways associated with lasting dysfunction | Dr. Angela M. Crawley | Ottawa Hospital Research Institute

    9:30 - 9:45 | Oral Abstract 2 | The Effect of Apoptosis and Inflammasome-Mediated Pyroptosis on HCV Infection | Hannah Louise Wallace | Memorial University

  • 09:45 10:00

    Coffee Break | Pause Café and Poster Browsing

  • 10:00 11:00

    Social, Cultural, Environmental, and Population Health Research – HCV in Underserved Populations: Modeling and Real‑Life Data to Inform Strategies

    Dr. Julie Bruneau (Co-Chair) | Université de Montréal
    Dr. Nadine Kronfi (Co-Chair) | McGill University
    CanHepC trainees introducing Plenary Speakers 


    10:00 - 10:20 | Session: Tackling HCV transmission among people who inject drugs: insights from modeling - Dr. Natasha Martin | University of California San Diego, USA

    10:20 - 10:40 | Session - Dr. Nadine Kronfi | McGill University

    10:40 - 11:00 | Questions/Panel Discussion 

  • 11:00 11:30

    Oral Presentations

    11:00 - 11:15 | Oral Abstract 1 | Effect of Sustained Virologic Response and Opioid Agonist Therapy on Mortality Among People Living with Chronic Hepatitis C | Dr. Prince Adu | University of British Columbia

    11:15 - 11:30 | Oral Abstract 2 | Community and Corrections Based Point-of-Care Testing into a Provincial Hepatitis C Elimination Framework | Dr. Lisa Barrett | Dalhousie University

  • 11:30 12:30

    Community Session ‑ “Connecting With Care” Videos and Panel Discussion

    Dr. Curtis Cooper (Co-Chair) | The Ottawa Hospital Research Institute
    Dr. Angela Crawley (Co-Chair) | The Ottawa Hospital Research Institute
    Melisa Dickie (Chair) | CATIE

  • 12:30 14:00

    Lunch and Poster Session | Présentation des Affiches

    13:00 - 13:45 | CanHepC evaluation of poster

  • 14:00 14:55

    Clinical Research ‑ Hepatitis C Infection in Pregnancy & Children

    Dr. Eve Roberts (Co-Chair) | Dalhousie University
    Dr. Hugo Soudeyns (Co-Chair) | Université de Montréal
    CanHepC trainees introducing Plenary Speakers 

    14:00 - 14:20 | DAA use in Pregnancy - Dr. Robert Honegger | Nationwide Children's, USA
    14:20 - 14:40 | Pediatric Perspectives on DDA Use - Dr. Simon Ling | University of Toronto, Canada
    14:40 - 14:55 | Questions/Panel Discussion

  • 14:55 15:25

    Oral Presentations

    14:55 - 15:10 | Oral Abstract 1 | Efficacy of Sofosbuvir/Velpatasvir (S/V): Impact of Treatment Adherence | Dr. Tianna Magel | Vancouver Infectious Diseases Centre, Vancouver, Canada

    15:10 - 15:25 | Oral Abstract 2 | Reinfection Following Successful Direct-Acting Antiviral Therapy for Hepatitis C Infection Among People Who Inject Drugs | Dr. Evan Cunningham | The Kirby Institute, UNSW, Sydney, Australia

  • 15:25 16:00

    Health Services Research – Blueprint Update and Implementation

    Dr. Curtis Cooper (Co-Chair) | The Ottawa Hospital Research Institute
    Dr. Angela Crawley (Co-Chair) | The Ottawa Hospital Research Institute
    CanHepC trainees introducing Plenary Speakers 

    15:25 - 15:45 | Panel Lead - Dr. Jordan Feld | University of Toronto
    15:45 - 16:00 | Questions/Panel Discussion

  • 15:45 16:00

    Coffee Break

  • 16:00 16:30

    Oral Presentations

    16:00 - 16:15 | Oral Abstract 1 | HBV-HCV Co Infection Among Immigrants in Ontario, Canada |Abdool S. Yasseen | University of Toronto, Canada

    16:15 - 16:30 | Oral Abstract 2 | The Health Burden of Hepatitis C Infection Facing the First Nations Population in Ontario: A Province-Wide Descriptive Analysis | Andrew Mendlowitz | University of Toronto, Canada

  • 16:30 16:40

    CanHepC Trainee Awards Ceremony

  • 16:40 16:45

    CanHepC Symposium Closing Remarks

    Dr. Curtis Cooper | The Ottawa Hospital Research Institute
    Dr. Angela Crawley | The Ottawa Hospital Research Institute

  • 16:45 16:55

    Canadian Liver Meeting Opening Remarks

    Dr. Marc Bilodeau | Université de Montreal, Montreal, Canada

  • 16:55 17:30

    CLM Opening Presentation ‑ Update on HCV Elimination in Canada and the US

    Dr. Andrew Aronsohn | University of Chicago 

  • 17:30 19:30

    Joint CanHepC and Canadian Liver Meeting Reception and CanHepC Poster Viewing